These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25416066)

  • 1. Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.
    Turner D; Doveh E; Cohen A; Wilson ML; Grossman AB; Rosh JR; Lu Y; Bousvaros A; Deslandres C; Noble A; Baldassano RN; Levine A; Lerner A; Wilson DC; Griffiths AM
    Gut; 2015 Dec; 64(12):1898-904. PubMed ID: 25416066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
    Haisma SM; Lijftogt T; Kindermann A; Damen G; de Ridder L; Escher JC; Mearin ML; de Meij T; Hendriks D; George E; Hummel T; Norbruis O; van Rheenen P
    J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.
    Harris RE; Aloi M; de Ridder L; Croft NM; Koletzko S; Levine A; Turner D; Veereman G; Neyt M; Bigot L; Ruemmele FM; Russell RK;
    BMJ Open; 2020 Jul; 10(7):e034892. PubMed ID: 32611737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study.
    van Dijkhuizen EH; Pouw JN; Scheuern A; Hügle B; Hardt S; Ganser G; Kümmerle-Deschner JB; Horneff G; Holzinger D; Bulatović Ćalasan M; Wulffraat NM
    Clin Exp Rheumatol; 2016; 34(1):148-54. PubMed ID: 26843067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic profiles for oral and subcutaneous methotrexate in patients with Crohn's disease.
    Wilson A; Patel V; Chande N; Ponich T; Urquhart B; Asher L; Choi Y; Tirona R; Kim RB; Gregor JC
    Aliment Pharmacol Ther; 2013 Feb; 37(3):340-5. PubMed ID: 23190184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis.
    Kopylov U; Katsanos KH; van der Woude CJ; Karmiris K; Hernandez V; Odes S; Papamichael K; Koutroubakis IE; Bojic D; Kaimakliotis I; Fiorino G; Papageorgiou N; Pineda JR; Strongili K; Sanroman L; Mantzaris GJ; Jojic N; Paspatis G; Christodoulou DK; Ben-Horin S; Tsianos EV
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):802-6. PubMed ID: 26894634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V; Wang Y; MacDonald JK; McDonald JW; Chande N
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006884. PubMed ID: 25157445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM; Iser JH; Gibson PR
    J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B; Lerner A; Shapiro R; Broide E; Levine A; Fradkin A; Bujanover Y
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease.
    Hojsak I; Mišak Z; Jadrešin O; Močić Pavić A; Kolaček S
    Scand J Gastroenterol; 2015; 50(10):1208-13. PubMed ID: 25877164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease.
    Sunseri W; Hyams JS; Lerer T; Mack DR; Griffiths AM; Otley AR; Rosh JR; Carvalho R; Grossman AB; Cabrera J; Pfefferkorn MD; Rick J; Leleiko NS; Hitch MC; Oliva-Hemker M; Saeed SA; Kappelman M; Markowitz J; Keljo DJ;
    Inflamm Bowel Dis; 2014 Aug; 20(8):1341-5. PubMed ID: 24983976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study.
    Uhlen S; Belbouab R; Narebski K; Goulet O; Schmitz J; Cézard JP; Turck D; Ruemmele FM
    Inflamm Bowel Dis; 2006 Nov; 12(11):1053-7. PubMed ID: 17075346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
    Walters TD; Kim MO; Denson LA; Griffiths AM; Dubinsky M; Markowitz J; Baldassano R; Crandall W; Rosh J; Pfefferkorn M; Otley A; Heyman MB; LeLeiko N; Baker S; Guthery SL; Evans J; Ziring D; Kellermayer R; Stephens M; Mack D; Oliva-Hemker M; Patel AS; Kirschner B; Moulton D; Cohen S; Kim S; Liu C; Essers J; Kugathasan S; Hyams JS;
    Gastroenterology; 2014 Feb; 146(2):383-91. PubMed ID: 24162032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V; Macdonald JK; McDonald JW; Chande N
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006884. PubMed ID: 19821390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center.
    Willot S; Noble A; Deslandres C
    Inflamm Bowel Dis; 2011 Dec; 17(12):2521-6. PubMed ID: 21337668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate in patients with Crohn's disease after 6-mercaptopurine.
    Mack DR; Young R; Kaufman SS; Ramey L; Vanderhoof JA
    J Pediatr; 1998 May; 132(5):830-5. PubMed ID: 9602195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis.
    Hazlewood GS; Thorne JC; Pope JE; Lin D; Tin D; Boire G; Haraoui B; Hitchon CA; Keystone EC; Jamal S; Bykerk VP;
    Ann Rheum Dis; 2016 Jun; 75(6):1003-8. PubMed ID: 25979945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Outcomes Over Time With Exclusive Enteral Nutrition Compared With Steroids in Children With Mild to Moderate Crohn's Disease: Results From the GROWTH CD Study.
    Cohen-Dolev N; Sladek M; Hussey S; Turner D; Veres G; Koletzko S; Martin de Carpi J; Staiano A; Shaoul R; Lionetti P; Amil Dias J; Paerregaard A; Nuti F; Pfeffer Gik T; Ziv-Baran T; Ben Avraham Shulman S; Sarbagili Shabat C; Sigall Boneh R; Russell RK; Levine A
    J Crohns Colitis; 2018 Feb; 12(3):306-312. PubMed ID: 29165666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody.
    Pichler J; Huber WD; Aufricht C; Bidmon-Fliegenschnee B
    World J Gastroenterol; 2015 Jun; 21(21):6613-20. PubMed ID: 26074699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.